ZA9811537B - Methods for regulating phagocytosis. - Google Patents

Methods for regulating phagocytosis.

Info

Publication number
ZA9811537B
ZA9811537B ZA9811537A ZA9811537A ZA9811537B ZA 9811537 B ZA9811537 B ZA 9811537B ZA 9811537 A ZA9811537 A ZA 9811537A ZA 9811537 A ZA9811537 A ZA 9811537A ZA 9811537 B ZA9811537 B ZA 9811537B
Authority
ZA
South Africa
Prior art keywords
methods
phagocytosis
regulating
regulating phagocytosis
Prior art date
Application number
ZA9811537A
Other languages
English (en)
Inventor
Miri Seiberg
Stanley S Shapiro
Magdalena Eisinger
Original Assignee
Johnson & Johnson Consumer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer filed Critical Johnson & Johnson Consumer
Publication of ZA9811537B publication Critical patent/ZA9811537B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Rheumatology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA9811537A 1997-12-16 1998-12-15 Methods for regulating phagocytosis. ZA9811537B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6979797P 1997-12-16 1997-12-16

Publications (1)

Publication Number Publication Date
ZA9811537B true ZA9811537B (en) 2000-06-27

Family

ID=22091272

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9811537A ZA9811537B (en) 1997-12-16 1998-12-15 Methods for regulating phagocytosis.

Country Status (13)

Country Link
EP (1) EP1037653B1 (ko)
JP (1) JP4689039B2 (ko)
KR (1) KR100601810B1 (ko)
CN (1) CN1188164C (ko)
AR (1) AR017216A1 (ko)
AU (4) AU1722099A (ko)
BR (1) BR9814284A (ko)
CA (1) CA2314899A1 (ko)
DE (1) DE69835832T2 (ko)
ES (1) ES2273445T3 (ko)
TW (1) TW590775B (ko)
WO (1) WO1999030729A1 (ko)
ZA (1) ZA9811537B (ko)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US6750229B2 (en) 1998-07-06 2004-06-15 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin pigmentation
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
YU61401A (sh) 1999-01-27 2005-07-19 Orto-Mcneil Pharmaceuticals Inc. U.S. Peptidil heterociklični ketoni korisni kao inhibitori triptaze
US7985404B1 (en) 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
WO2001034099A1 (en) † 1999-11-05 2001-05-17 Johnson & Johnson Consumer Companies, Inc. Soy depigmenting and skin care compositions
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
JP2006347926A (ja) * 2005-06-14 2006-12-28 Ichimaru Pharcos Co Ltd ファゴサイトーシス抑制剤
JP2011214909A (ja) * 2010-03-31 2011-10-27 Daiichi Sankyo Healthcare Co Ltd ケラチノサイトのメラノソーム取り込み輸送の検出方法
TWI493036B (zh) * 2013-12-24 2015-07-21 Ind Tech Res Inst 含一ｃｄ５４表現之報導系統之免疫細胞的應用以及一經選殖之新穎細胞

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63148952A (ja) * 1986-12-12 1988-06-21 Terumo Corp 加工大豆の製法
JP2618657B2 (ja) * 1987-10-02 1997-06-11 株式会社資生堂 抗色素沈着外用剤
EP0421021A1 (de) * 1989-10-06 1991-04-10 MUCOS EMULSIONSGESELLSCHAFT m.b.H. Verwendung katabolischer Enzyme zur Aktivierung von Makrophagen und/oder NK-Zellen, ein diese Enzyme enthaltendes Arzneimittel sowie durch diese Enzyme aktivierte Makrophage und/oder NK-zelle
JP3032566B2 (ja) * 1990-11-01 2000-04-17 株式会社資生堂 皮膚外用剤
US6030612A (en) * 1994-11-22 2000-02-29 Phairson Medical Inc. Antimicrobial uses of multifunctional enzyme
JPH07255406A (ja) * 1994-03-24 1995-10-09 Hisatomi Shokuhin Kogyo Kk 高度不飽和油脂強化大豆加工食品の製造方法

Also Published As

Publication number Publication date
ES2273445T3 (es) 2007-05-01
AU2010200198A1 (en) 2010-02-04
TW590775B (en) 2004-06-11
JP4689039B2 (ja) 2011-05-25
CA2314899A1 (en) 1999-06-24
DE69835832D1 (de) 2006-10-19
BR9814284A (pt) 2000-10-03
EP1037653A1 (en) 2000-09-27
KR20010015882A (ko) 2001-02-26
KR100601810B1 (ko) 2006-07-19
AR017216A1 (es) 2001-08-22
EP1037653B1 (en) 2006-09-06
CN1282254A (zh) 2001-01-31
JP2002508331A (ja) 2002-03-19
DE69835832T2 (de) 2007-04-05
AU1722099A (en) 1999-07-05
CN1188164C (zh) 2005-02-09
AU2003204412A1 (en) 2003-07-03
WO1999030729A1 (en) 1999-06-24
AU2006203246A1 (en) 2006-08-17

Similar Documents

Publication Publication Date Title
ZA967315B (en) Biphenylamides.
ZA9710429B (en) Broad-spectrumδ-endotoxins.
ZA973891B (en) Microparticles.
MX213417B (es) Fenilpiridazinonas.
ZA976168B (en) 3-Ureido-pyridofurans and -pyridothiophenes.
ZA979199B (en) Aminothiophenecarboxamides.
ZA977206B (en) Arylalkanoylpyridazines.
ZA964468B (en) Triazolylmethyl-cyclopentanols.
ZA978304B (en) 3-alkyl-3-phenyl-piperidines.
ZA989058B (en) Snack.
ZA961955B (en) Indazolecarboxamides.
DE69610844D1 (en) Hydroformylierungsverfahren.
ZA966773B (en) Sulfonyl-or sulfinyl-benzoylguanidin derivate.
ZA9811537B (en) Methods for regulating phagocytosis.
ZA979725B (en) Benzoaxozole derivative.
ZA969625B (en) 25-Hydroxy-16-ene-26, 27-bishomo-cholecalciferols
ZA966399B (en) Endothelin-receptor-antagonists.
ZA97572B (en) 1-pyrazol-3-ylethyl-4-indol-3-ylpiperidines.
ZA988637B (en) Methods for regulating trkA expression.
ZA976022B (en) Cycloalkano-pyridines.
ZA966750B (en) Halogenobenzimidazoles.
ZA966933B (en) Endothelin-receptor-antagonists.
ZA988206B (en) Piperidinylmethyloxazolidinone derivative.
ZA971466B (en) Endothelin-receptor-antagonists.
ZA969923B (en) Antioxidant.